Limitations and uncertainty about telehealth reimbursement have generally been an impediment to adoption. During the COVID-19 emergency, that stress was eased rather, but now the new typical is starting to acquire shape. What boundaries however keep on being to telehealth reimbursement, and how may they be conquer? To remedy that dilemma, host Jonah Comstock and Healthcare Finance News Managing Editor Susan Morse welcome McKinsey & Firm associates Oleg Bestsennyy and Gunjan Khanna.
This episode is introduced to you by BlueJeans.
Like what you listen to? Subscribe to the podcast on Apple Podcasts, Spotify or Google Enjoy!
- COVID-19 reimbursement changes and which of them will stick about
- Adoption lessons realized and how they’ll impact reimbursement coverage
- Holistic tele-treatment and treatment over and above the movie stop by
- Influence of new entrants and innovation on the house
- Is cost-for-support reimbursement an innovation blocker?
- Reimbursement for distinctive telehealth modalities
- Time to direct alternatively than follow for private payers?
- The however-unresolved dilemma of induced utilization
- The increase of value-primarily based treatment and hybrid treatment styles
- Telehealth reimbursement and overall health equity
- How are sufferers emotion about telehealth now?
- Closing thoughts: the future of telehealth reimbursement
A lot more about this episode:
Report reveals ‘vast improvement’ in point out telehealth reimbursement insurance policies
COVID-19 could forever alter the telehealth landscape, from reimbursement to utilization
Telehealth reimbursement parity spurs insurance provider concerns of overutilization
CMS will reimburse for 11 new telehealth products and services during the public overall health emergency
Congressional action is needed for telehealth not to return to a rural advantage, Seema Verma states
Telehealth: A quarter-trillion-greenback write-up-COVID-19 fact? (McKinsey)
COVID-19 Customer Healthcare Insights: What 2021 could hold (McKinsey)
How COVID-19 has adjusted the way US individuals believe about healthcare (McKinsey)